Clarivate PLC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Clarivate Plc announced the appointment of Michael Easton as its new Executive Vice President & Chief Financial Officer, effective August 8, 2026, succeeding Jonathan Collins.
NYSE
Clarivate Plc announced its second quarter 2026 financial results, reporting a net loss of $268.6 million, primarily due to a significant non-cash goodwill impairment charge, while reaffirming its full-year financial outlook.
NYSE
Clarivate Plc announced a definitive agreement to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for $600 million.
NYSE
Clarivate Plc has appointed former CPA Global CEO Simon Webster as President of its Intellectual Property segment, succeeding Maroun S. Mourad.
NYSE
Clarivate Plc shareholders approved all proposals at the 2026 Annual General Meeting, including director elections and executive compensation.
NYSE
Clarivate Plc announced its first quarter 2026 financial results, showing progress on its Value Creation Plan and reaffirming its full-year financial outlook.
NYSE
Clarivate Plc has adopted an Amended and Restated Executive Severance Plan, expanding eligibility and modifying equity vesting terms for executives, particularly in change-of-control scenarios.
NYSE
Clarivate Plc reported strong fourth quarter and full year 2025 results, exceeding financial guidance, and announced plans to sell its Life Sciences & Healthcare business to sharpen strategic focus.
NYSE
Clarivate PLC announced it has posted a video webinar titled 'Intelligence Amplified in the Age of AI' along with related presentation materials to its investor relations website.
NYSE
Clarivate Plc announced the full redemption of its remaining $100 million senior secured notes due 2026 and significant share repurchases in 2025, signaling a focus on debt reduction and shareholder returns.
NYSE
Clarivate Plc reported improved Q3 2025 net loss and raised its full-year revenue guidance, driven by organic ACV growth and strategic initiatives.
NYSE
Clarivate PLC and its subsidiaries amended their credit agreement, increasing total revolving credit commitments by $75 million to an aggregate of $775 million.
NYSE
Clarivate Plc has announced a leadership transition in its Intellectual Property segment, with Gordon Samson departing and Maroun S. Mourad appointed as the new President, alongside a board resignation.
NYSE
Clarivate Plc announced second quarter 2025 results showing improved net loss and positive organic revenue growth, despite overall revenue declines due to strategic divestitures, while reaffirming its full-year 2025 outlook.
NYSE
Clarivate Plc announced the election of Kenneth Cornick, co-founder and former President and CFO of Clear Secure, Inc., to its Board of Directors, increasing the board size to eleven members.
NYSE
Clarivate Plc has successfully completed a refinancing transaction, securing a new $500 million incremental term loan maturing in 2031, and using the proceeds to redeem the majority of its 4.50% Senior Secured Notes due 2026.
NYSE
Clarivate Plc's subsidiary, Camelot Finance S.A., plans to redeem $500 million of its 4.50% Senior Secured Notes due 2026, contingent on successful debt financing.
NYSE
Clarivate Plc held its 2025 Annual General Meeting where shareholders approved all proposals, including the election of directors, executive compensation, auditor ratification, an incentive award plan, and authorization for share repurchases.
NYSE
Clarivate Plc reports a slight decrease in total revenue for Q1 2025, but reaffirms its 2025 outlook, citing accelerated recurring organic revenue growth and strategic share repurchases.
NYSE
Michael J. Angelakis will retire from Clarivate PLC's Board of Directors effective upon the re-election of board members at the 2025 Annual General Meeting of Shareholders.
NYSE
Clarivate's Q4 2024 results show a slight revenue decrease but improved net loss, while the company initiates a strategic review including potential divestitures.
NYSE
Clarivate's Board of Directors has authorized a new $500 million share repurchase program, replacing the existing program and signaling confidence in the company's growth prospects.
NYSE
Clarivate Plc has amended the retirement date of board member Richard Roedel from December 31, 2024, to January 1, 2025.
NYSE
Clarivate's third quarter results were disappointing, with a 3.9% revenue decrease and a net loss of $65.6 million, leading to the removal of their 2024 financial outlook.
NYSE
Clarivate has announced the appointment of Matti Shem Tov as its new CEO, succeeding Jonathan Gear, effective August 9, 2024.
NYSE
Clarivate's second quarter results show a revenue decrease, but the company reaffirms its 2024 outlook and anticipates a return to organic growth in the second half of the year.
NYSE
Clarivate PLC announces the retirement of director Richard Roedel due to health reasons, with Valeria Alberola set to take over as Audit Committee Chair.
NYSE
Clarivate Plc successfully held its 2024 Annual General Meeting, electing directors and approving executive compensation and auditor ratification.
NYSE
Clarivate's first quarter results show a slight revenue decrease and a net loss, but the company reaffirms its 2024 outlook.
NYSE
Clarivate has entered into an investment agreement with Exor N.V., resulting in a board seat for Exor's Chief Operating Officer and certain standstill restrictions for Exor.